Underlying Data
2171 CARSGEN-B
13.00
+0.670
(+5.43%)
Bid: 12.88
Ask: 13.00
12.23
14.64M
7.33B
13.00
12.33
1.14M
-66.01
12.23
12.33
500
0.00 %
57.25
10.02
12.23
12.33
14.64M
1.14M
7.33B
-66.01
13.00
12.23
500
0.00 %
57.25
10.02
12.33
Description: CARSGEN is a Chinese innovative pharmaceutical company focused on developing CAR-T cell therapies for the treatment of hematologic malignancies and solid tumors.
Industry: Pharma
Last Updated:06-10-26 16:20 (15 minutes delayed)
Similar Product
Information Provided by DB Power Online Limited
[Disclaimer]